miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. (Q38939457)

7 September 2017

miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. (English)

1 reference

7 September 2017

multiple drug resistance

1 reference

Ye Zhang

1

1 reference

7 September 2017

Xiujuan Qu

2

1 reference

7 September 2017

Ce Li

3

1 reference

7 September 2017

Yibo Fan

4

1 reference

7 September 2017

Xiaofang Che

5

1 reference

7 September 2017

Ximing Wang

6

1 reference

7 September 2017

Ying Cai

7

1 reference

7 September 2017

Xuejun Hu

8

1 reference

7 September 2017

Yunpeng Liu

9

1 reference

7 September 2017

19 November 2014

1 reference

7 September 2017

1 reference

7 September 2017

36

1 reference

7 September 2017

2277-2285

1 reference

7 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2835-7

7 September 2017

0 references

cites work

Current questions for the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Emerging roles for modulation of microRNA signatures in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Strategies to determine the biological function of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Function of miRNA in controlling drug resistance of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

The role of E3 ubiquitin ligase Cbl proteins in β-elemene reversing multi-drug resistance of human gastric adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Collateral sensitivity as a strategy against cancer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2835-7

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25407491

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The challenge of developing robust drugs to overcome resistance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25407491

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2835-7

1 reference

Dimensions Publication ID

7 September 2017

1003860159

0 references

Fatcat ID

release_htvzrbgqj5bltb2u2x7vcqkfqq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/htvzrbgqj5bltb2u2x7vcqkfqq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference